Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novartis AG

131.43
+0.66000.50%
Post-market: 131.430.00000.00%19:51 EDT
Volume:1.33M
Turnover:174.38M
Market Cap:254.43B
PE:19.19
High:132.44
Open:130.57
Low:130.41
Close:130.77
52wk High:133.55
52wk Low:96.06
Shares:1.94B
Float Shares:1.84B
Volume Ratio:0.78
T/O Rate:0.07%
Dividend:3.86
Dividend Rate:2.94%
EPS(TTM):6.85
EPS(LYR):5.92
ROE:32.49%
ROA:11.88%
PB:6.06
PE(LYR):22.21

Loading ...

Novartis AG (NVS.US) CD20-Targeting Therapy Maintains High Efficacy for Up to 7 Years with Patient Self-Injection Option

Stock News
·
Sep 26

Eli Lilly Stock Is Trading Down Thursday: What's Behind The Move?

Benzinga_recent_news
·
Sep 26

Novartis increased its stockpiles of pharmaceuticals in the U.S., Reuters says

TIPRANKS
·
Sep 22

Novartis looking into price cut proposals for U.S., Bloomberg reports

TIPRANKS
·
Sep 22

Novartis AG CEO Says Company Studying Price Reduction Plans for US Market, Maintains Revenue Growth Outlook

Deep News
·
Sep 20

Novartis Signs Licensing Deal Worth Up to $5.7 Billion with Monte Rosa Therapeutics

Deep News
·
Sep 15

Novartis Shares Fall After Goldman Sachs Downgrade

MT Newswires Live
·
Sep 13

Novartis Catches a 'Sell.' Goldman Sachs Says the Stock Is Overvalued. -- Barrons.com

Dow Jones
·
Sep 13

Novartis (NVS) was downgraded to a Sell Rating at Goldman Sachs

TIPRANKS
·
Sep 12

Goldman Sachs Downgrades Novartis to Sell From Neutral, Adjusts Price Target to $118 From $119

MT Newswires Live
·
Sep 12

Novartis Cut to Sell From Neutral by Goldman Sachs

Dow Jones
·
Sep 12

Goldman Sachs Downgrades Novartis AG (NVS.US) to "Sell" Amid Generic Competition and Questioned Growth Narrative

Stock News
·
Sep 12

Novartis AG Rises Thursday, Outperforms Market

Dow Jones
·
Sep 12

Top Premarket Gainers

MT Newswires Live
·
Sep 09

Why JPMorgan is warning the Fed rate cut everyone expects could sink stocks

Dow Jones
·
Sep 09

Novartis to buy U.S. biotech in latest deal targeting firms in $1 billion to $3 billion range

Dow Jones
·
Sep 09

Novartis to Acquire Tourmaline Bio in Deal Valuing It at $1.4 Billion

Reuters
·
Sep 09

Novartis AG Falls Monday, Underperforms Market

Dow Jones
·
Sep 09

U.S. RESEARCH ROUNDUP-Apple, Sanofi, Watts Water Technologies

Reuters
·
Sep 08

Novartis AG Rises Friday, Outperforms Market

Dow Jones
·
Sep 06